XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 3,051 $ 1,566
Accounts receivable, net of allowance of $1,318 and $1,674, respectively 110,994 137,544
Inventory 89,632 84,622
Other current assets 6,946 8,228
Total current assets 210,623 231,960
Property, plant and equipment, net 2,246,245 2,199,253
Operating lease right-of-use assets 16,111 16,706
Intangible assets, net 35,196 37,077
Contract costs, net 35,998 34,736
Deferred tax assets 29,146 33,353
Other assets 38,307 37,079
Non-current assets of discontinued operations 8,280 8,586
Total assets 2,619,906 2,598,750
Current liabilities:    
Accounts payable, trade 78,999 64,324
Accrued liabilities 92,213 76,915
Deferred revenue 5,889 7,332
Total current liabilities 177,101 148,571
Long-term debt 1,547,274 1,548,334
Operating lease liabilities 14,170 14,861
Deferred tax liabilities 934 854
Other liabilities 19,509 17,569
Non-current liabilities of discontinued operations 7,868 7,868
Total liabilities 1,766,856 1,738,057
Commitments and contingencies (Note 6)
Equity:    
Preferred stock - $0.01 par value, 50,000,000 shares authorized, zero issued
Common stock: $0.01 par value 250,000,000 shares authorized, 164,903,900 and 163,439,013 shares issued, respectively 1,649 1,634
Additional paid-in capital 3,460,259 3,456,777
Accumulated deficit (2,516,500) (2,509,133)
Treasury stock: 8,207,390 and 7,810,548 common shares, at cost, respectively (92,358) (88,585)
Total equity 853,050 860,693
Total liabilities and equity $ 2,619,906 $ 2,598,750